Association of lung immune prognostic index (LIPI) with survival of first line immune checkpoint inhibitors single agent or in combination with chemotherapy in untreated advanced NSCLC patients

被引：0

作者：

Blanc-Durand, F. ^{[1
]}

Auclin, E. ^{[2
]}

Planchard, D. ^{[1
]}

Ponce Aix, S. ^{[3
]}

Hendriks, L. ^{[4
]}

Sullivan, I. G. ^{[5
]}

Saravia, D. ^{[6
]}

Routy, B. ^{[7
]}

Lopez Castro, R. ^{[8
]}

Pilotto, S. ^{[9
]}

Aboubakar, F. ^{[10
]}

Kassouf, E. ^{[11
]}

Rodriguez, A. ^{[12
]}

Amores Martin, A. ^{[13
]}

Bluthgen, M. V. ^{[14
]}

Duchemann, B. ^{[15
]}

Caramella, C. ^{[16
]}

Nadal, E. ^{[17
]}

Besse, B. ^{[1
]}

Mezquita, L. ^{[1
]}

机构：

[1] Inst Gustave Roussy, Med Oncol, Villejuif, France

[2] Hop European George Pompidou, Gastrointestinal & Med Oncol Dept, Paris, France

[3] Univ Hosp 12 Octubre, Med Oncol, Madrid, Spain

[4] Maastricht Univ, Med Ctr, Pulm Dis, Maastricht, Netherlands

[5] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain

[6] Jackson Mem Hosp, Hematol Oncol Dept, Miami, FL 33136 USA

[7] Univ Montreal, Res Ctr, Hematooncol, Montreal, PQ, Canada

[8] Univ Clin Hosp Valladolid, Med Oncol, Valladolid, Spain

[9] AOU Integrata Borgo Roma Verona, Med Oncol, Verona, Italy

[10] UC Louvain Brussels Woluwe, Dept Oncol Thorac, Brussels, Belgium

[11] Ctr Hosp Reg Lanaudiere, Med Oncol, St Charles Borromee, PQ, Canada

[12] Inst Clin Malalties Hematol & Oncol, Med Oncol, Barcelona, Spain

[13] Hosp Clin Univ Salamanca, Med Oncol, Salamanca, Spain

[14] Hosp Aleman, Med Oncol, Buenos Aires, DF, Argentina

[15] Hop Avicenne, Med Oncol, Bobigny, France

[16] Inst Gustave Roussy, Radiol, Villejuif, France

[17] ICO, Med Oncol, Barcelona, Spain

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

17P

引用

页码：5 / 5

页数：1

共 50 条

[31] Identification of prognostic nutritional index as a reliable prognostic indicator for advanced lung cancer patients receiving immune checkpoint inhibitors
Yan, Xuebing
Wang, Jiaxin
Mao, Jingxian
Wang, Ying
Wang, Xiangjun
Yang, Mengxue
Qiao, Hong
FRONTIERS IN NUTRITION, 2023, 10
[32] Correlation of lung immune prognostic index with the efficacy of immune checkpoint inhibitors in Chinese patients with advanced non-small cell lung cancer
Xiaoyu Zhi
Zhibo Zhang
Weiwei Li
Zhouhuan Dong
Xiaodong Wu
Xiangwei Ge
Jinzhao Zhai
Di Lu
Xiang Yan
Jinliang Wang
Holistic Integrative Oncology, 3 (1):
[33] Validation of the Lung Immune Prognostic Index (LIPI): Useful to Identify Resistance to PD-1 Checkpoint Inhibitors in Pretreated Lung Cancer
Mielgo-Rubio, X.
Sereno Moyano, M.
Sotelo-Lezama, M.
Lopez Castro, R.
Rubio-Martinez, J.
Velastegui, A.
Olier-Garate, C.
Falagan, S.
Gomez-Barreda, I.
Riquelme, A.
Cardena-Gutierrez, A.
Moreno Rubio, J.
Lopez, C.
Bueno, C.
-Ruiz, J. Silva
Zhou, E. Zhan
Chara, L.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S488 - S489
[34] Proton Pump Inhibitors, Prior Therapy and Survival in Patients Treated With Immune Checkpoint Inhibitors for Advanced NSCLC
Husain, M.
Xu, M.
Patel, S.
Johns, A.
Grogan, M.
Li, M.
Lopez, G.
Miah, A.
Hoyd, R.
Liu, Y.
Muniak, M.
Haddad, T.
Tinoco, G.
Kendra, K.
Otterson, G.
Presley, C.
Spakowicz, D.
Owen, D.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1076 - S1076
[35] Predictive and Prognostic Value of CTC Monitoring in Advanced NSCLC Patients Treated with Immune Checkpoint Inhibitors
Gao, G.
Li, J.
Zhou, F.
Li, W.
Xiong, A.
Chen, X.
Ren, S.
Zhou, C.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S730 - S730
[36] Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma
Parent, Pauline
Auclin, Edouard
Patrikidou, Anna
Mezquita, Laura
Chanza, Nieves Martinez
Dumont, Clement
Rodriguez-Vida, Alejo
Llacer, Casilda
Lozano, Rebeca
Ratta, Raffaele
Merseburger, Axel S.
Sternberg, Cora N.
Baciarello, Giulia
Colomba, Emeline
Fuerea, Alina
Besse, Benjamin
Loriot, Yohann
Lavaud, Pernelle
CANCERS, 2023, 15 (04)
[37] Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non-small cell lung cancer
Kuo, Chih-Hsi Scott
Wang, Chin-Chou
Huang, Yu-Chen
Pavlidis, Stelios
Liu, Chien-Ying
Ko, How-Wen
Chung, Fu-Tsai
Lin, Tin-Yu
Wang, Chih-Liang
Guo, Yi-Ke
Yang, Cheng-Ta
THORACIC CANCER, 2019, 10 (05) : 1158 - 1166
[38] A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors
Khaki, Ali Raza
Li, Ang
Diamantopoulos, Leonidas N.
Miller, Natalie J.
Carril-Ajuria, Lucia
Castellano, Daniel
De Kouchkovsky, Ivan
Koshkin, Vadim
Park, Joseph
Alva, Ajjai
Bilen, Mehmet A.
Stewart, Tyler
Santos, Victor
Agarwal, Neeraj
Jain, Jayanshu
Zakharia, Yousef
Morales-Barrera, Rafael
Devitt, Michael
Nelson, Ariel
Hoimes, Christopher J.
Shreck, Evan
Gartrell, Benjamin A.
Sankin, Alex
Tripathi, Abhishek
Zakopoulou, Roubini
Bamias, Aristotelis
Rodriguez-Vida, Alejo
Drakaki, Alexandra
Liu, Sandy
Kumar, Vivek
Lythgoe, Mark P.
Pinato, David J.
Murgic, Jure
Frobe, Ana
Joshi, Monika
Velho, Pedro Isaacsson
Hahn, Noah
Buznego, Lucia Alonso
Duran, Ignacio
Moses, Marcus
Barata, Pedro
Galsky, Matthew D.
Sonpavde, Guru
Yu, Evan Y.
Shankaran, Veena
Lyman, Gary H.
Grivas, Petros
EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (03): : 464 - 472
[39] Immune Checkpoint Inhibitors Plus Chemotherapy as First-Line Treatment in Patients with Advanced Pulmonary Sarcomatoid Carcinoma
Wu, F.
Du, H.
Chen, S.
Li, J.
Gao, G.
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S404 - S404
[40] Lung immune prognostic index (LIPI) as a prognostic factor in patients with extensive-stage small cell lung cancer treated with first-line chemoimmunotherapy
Herranz-Bayo, Elena
Chara-Velarde, Luis Enrique
Cassinello-Espinosa, Javier
Gimeno-Ballester, Vicente
Artal-Cortes, Angel
Moratiel-Pellitero, Alba
Alcacera-Lopez, Arancha
Navarro-Exposito, Fatima
Riesco-Montes, Blanca
Clemente-Andujar, Manuel
CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, : 1484 - 1492

← 1 2 3 4 5 →